Pharmacological PINK1 activation Ameliorates Pathology in Parkinson’s Disease Models
Time: 11:45 am
day: Day One
Details:
- Improving mitochondrial quality control as a treatment for Parkinson’s and chronic diseases of mitochondrial dysfunction
- Combining genetically validated targets with small molecules to create a novel therapeutic modality
